DVM—Newsmagazine of Veterinary Medicine
October 1, 2006

SNAP^® 4Dx^® was unveiled at CVC Central. The test allows veterinarians to screen for heartworm, ehrlichiosis, Lyme disease and anaplasmosis.

Westbrook, Maine—IDEXX Laboratories introduces the Snap^® 4Dx^® Test, an in-house test that lets veterinarians screen for heartworm, ehrlichiosis, Lyme disease and anaplasmosis.

The company reports the test helps support veterinarians by managing the growing anaplasmosis incidence by:

• Finding the presence of Anaplasma phagocytophilum exposure—the tick-borne pathogen.

• Helping DVMs identify infected patients prone to clinical disease.

• Educate on the incidence of risk and disease in the area.

• Reinforce strategies for tick control and disease prevention.

The test is affordable and delivers accurate screening results with at least a 98-percent specificity on all four diseases, the company reports.

Dogs exposed to Anaplasma phagocytophilum (E. equi) are at risk for getting sick.

Supporting clinical signs for an anaplasmosis diagnosis are lameness, anorexia, petechia, lethargy and fever. Supporting CBC/chemistry evidence of anaplasmosis includes thrombocytopenia, lymphopenia, leukopenia and hyperglobulinemia, the company reports.

IDEXX has a firm commitment to your privacy. We do not sell or share information
with third parties. View our full Privacy Policy and Terms of Use